OverviewChartNewsTraderScreen

E.ON SE/  US2687801033  /

Nasdaq Other OTC
2024-05-20  9:45:52 PM Chg. +0.0400 Volume Bid- Ask- High Low
13.7700USD +0.29% 19,958
Turnover: 251,961.8505		 -Bid Size: - -Ask Size: - 13.8200 13.7350
TeleTrader 5:30 PM Europe closes higher ahead of major data
TeleTrader 9:01 AM Europe opens higher eyeing inflation reports
GlobeNewswire 8:00 AM LEADING EDGE MATERIALS APPOINTS KURT BUDGE AS CHIEF EXECUTIVE OFFICER
GlobeNewswire 05-17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 05-07 ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
GlobeNewswire 05-06 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 04-25 Gatos Silver Reports South-East Deeps Drilling Results at Cerro Los Gatos and Announces Executive Ap...
GlobeNewswire 04-23 ITM, Helmholtz Munich and University Hospital Münster Announce First Patient Dosed in Phase I Invest...
GlobeNewswire 04-22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 04-07 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 04-04 AINewsWire Named Official Newswire of R.AI.SE Summit
GlobeNewswire 03-20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 03-20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 03-11 BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...
GlobeNewswire 03-11 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 03-07 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...
GlobeNewswire 03-07 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 03-06 BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...
GlobeNewswire 03-03 BNTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Befo...
GlobeNewswire 02-28 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...
GlobeNewswire 02-23 BNTX DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses t...
GlobeNewswire 02-23 BIONTECH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encou...
GlobeNewswire 02-16 ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Befo...
GlobeNewswire 02-15 BIONTECH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Securities Litigation Partner James (Jo...
GlobeNewswire 02-11 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Import...